The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,453,896 in first-year total cost, median $1,453,896.
Most frequent study sections
- Medication Development Research Study Section[NIDA-L]1
Most frequent institutions
- UNIVERSITY OF MARYLAND BALTIMORE1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2022 | PTPRD phosphatase inhibitors for stimulant use disorders1UG3DA056039-01 | UHL, GEORGE RICHARD | UNIVERSITY OF MARYLAND BALTIMORE, MD | $1,453,896 | NIDA |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.